When a defense expert stands up in 2026 and tells a jury that your client’s lingering headaches, memory gaps, and emotional outbursts are “functional” rather than “organic,” the word carries an unmistakable subtext: not real, not compensable, possibly fabricated. This is the functional neurological disorder post-concussion syndrome TBI misdiagnosis problem that is quietly reshaping brain injury litigation—and costing plaintiffs tens of thousands of dollars in suppressed awards before a single closing argument is delivered.
Understanding why this argument is both medically incomplete and legally attackable is no longer optional for plaintiffs’ counsel. A June 2026 scoping review published in Life 16(6):926 confirmed that the overlap between persistent post-concussion syndrome (PPCS) and functional neurological disorder (FND) “remains poorly synthesised and conceptually unresolved”—meaning the science itself has not settled the debate. Defendants who present FND as a clean alternative to organic TBI are overstating what the literature actually supports. This post shows you how to expose that gap, credential the right experts, and protect your client’s recovery from the moment you file.
What FND Is—and What It Is Not—in 2026 Clinical Science
Functional neurological disorder describes a condition in which a patient experiences genuine, often severely disabling neurological symptoms that are incompatible with recognized neurological disease and typically arise in the absence of structural brain damage. The DSM-5 classification removed the old requirement of a psychological stressor, which means FND is no longer shorthand for “it’s all in your head”—it is a recognized condition producing, as Phillips & Edwards noted in BMJ Neurology in 2025, “very high levels of disability” and one of the most common presentations seen by neurologists today. Despite this, FND remains “stigmatized and underrecognized” in legal settings, a gap that defense teams exploit in the opposite direction: using FND as a coded accusation of exaggeration.
Post-concussion syndrome, by contrast, is a documented sequela of traumatic brain injury. A patient who sustains a blow to the head, experiences altered consciousness, and then develops cognitive dysfunction, emotional dysregulation, headaches, and sleep disturbances has a recognized mechanistic pathway linking the physical event to the symptoms. The core litigation problem in 2026 is that PCS and FND “exhibit considerable clinical overlap” in cognitive dysfunction, emotional dysregulation, and symptom persistence—even when neuroimaging is negative, according to Mavroudis et al. 2025. Negative imaging does not equal no injury. Mild TBI routinely produces no visible abnormality on standard MRI or CT, yet leaves behind measurable functional and neurochemical disruption.
For plaintiffs injured in motor vehicle collisions where TBI is alleged, using a car accident settlement calculator can help approximate baseline economic damages before the diagnostic dispute even enters negotiations—but only if the underlying medical record is built to withstand an FND challenge. That construction begins at the very first clinical visit.
The Differential Diagnosis Framework That Survives Cross-Examination
The defense FND argument thrives in a diagnostic vacuum. If your client’s treating team never formally engaged the differential between PCS and FND, the defense expert fills that silence with their preferred narrative. A robust differential diagnosis framework does four things: it documents the traumatic mechanism, eliminates confounders, applies structured diagnostic criteria to both conditions simultaneously, and reaches a causally coherent conclusion. Each of those steps must survive Daubert scrutiny.
Step One: Mechanistic Documentation
Counsel should work with treating physicians to ensure the record contains a clear description of the biomechanical event—direction of force, loss of consciousness (even brief), post-traumatic amnesia window, and acute GCS score if available. Mild TBI by CDC definition includes a GCS of 13–15, any loss of consciousness up to 30 minutes, and post-traumatic amnesia up to 24 hours. Symptoms that emerge within this window and persist beyond the expected recovery timeline create the foundation for a PCS diagnosis under CDC TBI clinical criteria.
Step Two: Ruling Out Pure FND Presentations
FND typically has identifiable positive signs—Hoover’s sign for functional leg weakness, entrainment for functional tremor, and other bedside markers. These are absent in most PCS presentations. The 2026 Life scoping review specifically noted that the interface between PPCS and FND is “poorly synthesised,” which means experts who testify that FND cleanly explains post-TBI symptoms are going beyond what peer-reviewed literature supports. Counsel can use this directly in cross-examination: ask the defense expert to identify which positive FND signs were documented in the treating record.
Step Three: Addressing the Psychological Layer Without Conceding the Narrative
Depression, anxiety, PTSD, and somatization commonly co-occur with mild TBI. Defense teams use comorbid psychiatric diagnoses to suggest symptoms are emotional rather than structural. The correct response is not to deny the psychiatric layer but to explain it as a predictable consequence of neurological injury—a causal chain from structural insult to behavioral sequelae. This is precisely where a forensic neuropsychiatrist, not a standard neurologist or neuropsychologist, becomes indispensable. For clients injured in commercial truck crashes, quantifying the interaction between economic loss and neuropsychiatric injury is critical—a truck accident calculator can capture baseline damages while the expert builds the clinical narrative.
Why Forensic Neuropsychiatry Is the Essential Expert Class in FND Defense
There are fewer than 20 board-certified forensic neuropsychiatrists in the United States as of 2026. This scarcity matters strategically. Neurologists can testify to structural injury findings but carry no psychiatric training and cannot credibly opine on how depression, PTSD, or somatization interacts with TBI pathophysiology. Neuropsychologists can document cognitive deficits through testing but, critically, are generally restricted by courts from offering opinions on brain-behavior causation—that is, whether a specific injury caused a specific behavioral outcome. Judges applying Daubert and Frye standards in 2024 through 2026 have increasingly limited expert opinions that cross into credibility determinations, which is where neuropsychological testimony about “malingering” most often goes wrong.
A forensic neuropsychiatrist, as described by Wortzel in 2022 and updated by Lodhi in 2026, integrates neuroimaging analysis, psychiatric differential diagnosis, and a medically coherent causal chain from structural injury to behavioral sequelae. Critically, this expert can address depression, anxiety, PTSD, somatization, and malingering within a single unified opinion—something neither a neurologist nor a neuropsychologist alone can do. When defense counsel attacks one component of that opinion, the entire architecture holds because it was built as an integrated whole, not a patchwork of siloed testimonies.
Counsel should retain this expert early—before the defense retains theirs. The forensic neuropsychiatrist’s role at the outset is not testimonial but strategic: reviewing the treating record, identifying diagnostic gaps, recommending additional evaluations (functional MRI, quantitative EEG, neuropsychiatric assessment), and flagging documentation vulnerabilities before they become deposition targets. This expert’s opinion, when properly disclosed, also serves as a preemptive answer to the FND-as-exaggeration narrative that the defense will otherwise build unchallenged.
Daubert Challenges to Performance Validity Testing: A 2026 Litigation Tool
Performance validity testing (PVT) has become the defense’s preferred mechanism for suggesting malingering in functional neurological disorder post-concussion syndrome TBI misdiagnosis cases. The theory is straightforward: if a plaintiff performs below statistical chance on a test designed to detect effort, they are not trying, and therefore their symptoms are not genuine. Courts in 2024 through 2026 have increasingly questioned whether this inference survives Daubert scrutiny.
The scientific challenge is grounded in McWhirter et al., published in the Journal of Neurology, Neurosurgery & Psychiatry and cited in a federal order in 2024: the provision of multiple PVTs administered in a single neuropsychological battery “invalidates scientific validity” because base-rate failure rates compound across administrations. A plaintiff who passes four PVTs but fails a fifth may be classified as a “malingerer” under standard cutoffs, even though the probability of at least one false-positive failure across five tests far exceeds acceptable scientific margins. Courts applying Federal Rule of Evidence 702 require that expert testimony be based on sufficient facts, reliable methodology, and reliable application of that methodology to the facts. When PVT batteries are designed to maximize failure rates and the scientific literature says the resulting inference is unreliable, a Daubert motion to exclude or limit that opinion is viable.
Counsel should request the complete neuropsychological raw data file under applicable discovery rules, identify how many PVTs were administered, research the specific compound failure-rate probability using psychometric literature, and file a targeted Daubert motion citing McWhirter and any federal court orders citing the same source. The goal is not necessarily to exclude the entire neuropsychological opinion—it is to surgically remove the malingering conclusion while leaving valid cognitive deficit findings intact. Removing the malingering label while keeping the disability documentation serves the plaintiff.
Settlement Value Implications: What FND Confusion Actually Costs Plaintiffs
The financial stakes of functional neurological disorder post-concussion syndrome TBI misdiagnosis are not speculative. Data from meta-analyses and WHO task force research quantify the damage.
| Scenario | Estimated Award Impact | Source |
|---|---|---|
| Organic mild TBI with PCS, no FND dispute | Baseline (100%) | Belanger meta-analysis |
| FND label introduced by defense expert | 30–50% reduction vs. organic TBI | WHO Task Force / Belanger meta-analysis |
| Malingering label survives Daubert challenge | Up to 60% reduction or defense verdict | Litigation psychology research |
| Forensic neuropsychiatrist retained by plaintiff | Restores baseline range; counters FND narrative | Wortzel 2022, Lodhi 2026 |
| Litigation stress feedback loop unaddressed | Symptom worsening documented; jury skepticism increases | WHO Task Force |
The feedback loop documented by the WHO Task Force is particularly damaging: litigation stress itself worsens PCS symptoms, which defense teams then point to as evidence of symptom amplification or FND. This circular argument—your client’s symptoms are worse because they’re in litigation, therefore litigation-related secondary gain explains the symptoms—can only be neutralized by expert testimony that distinguishes neurobiological stress response from motivated exaggeration. This is again forensic neuropsychiatric territory. To understand how diagnostic disputes translate to dollar differences in general personal injury claims, a personal injury settlement calculator can provide a useful starting framework, though actual outcomes depend heavily on expert credentialing and the resolution of the FND dispute.
Statute of Limitations and the Discovery Rule in FND-Complicated TBI Cases
A secondary litigation risk in functional neurological disorder post-concussion syndrome TBI misdiagnosis cases involves timing. Atypical post-head-injury presentations—emotional outbursts, episodic memory loss, concentration failures—may initially appear temporary or be misattributed to stress, grief, or adjustment difficulty. Clients may not connect these symptoms to the original trauma for months or years. When a definitive TBI or PCS diagnosis finally arrives, the question of when the statute of limitations clock started running becomes critical.
Under the discovery rule applied in Tennessee and multiple other jurisdictions in 2026, the statute of limitations does not require a definitive medical diagnosis to begin running—it requires that the plaintiff knew or should have known they sustained an injury caused by another’s conduct. The practical implication for FND-complicated cases is that a plaintiff who was told by early-treating physicians that symptoms were “functional” or “stress-related” may have a strong argument that the discovery clock did not start until a competent clinician connected the symptom complex to the underlying TBI. Rocky McElhaney’s 2026 Tennessee analysis of this principle confirms that courts are receptive to discovery-rule tolling arguments where the diagnostic picture was genuinely ambiguous due to the FND-PCS overlap. Counsel should document the timeline of misdiagnosis carefully, because the same clinical literature that creates the FND defense problem also creates the discovery-rule opportunity.
For context on how state-specific statutes interact with TBI discovery rules, Justia’s brain injury resource section provides jurisdiction-by-jurisdiction guidance on applicable limitations periods.
Preempting the FND-as-Exaggeration Narrative: A Plaintiff’s Strategy Checklist
The single most effective litigation strategy in functional neurological disorder post-concussion syndrome TBI misdiagnosis cases is preemption. Once the defense has filed its FND expert disclosure, you are playing defense. The following steps, executed early, shift the burden.
- Retain a forensic neuropsychiatrist within 90 days of filing to audit the treating record for diagnostic gaps and recommend supplemental evaluations before the defense IME occurs.
- Request advanced neuroimaging if standard MRI is negative—diffusion tensor imaging (DTI) and functional MRI document microstructural and connectivity disruptions invisible to conventional sequences.
- Brief treating physicians on the FND-PCS overlap so they document positive PCS indicators and explicitly engage (and rule out) FND in their clinical notes.
- Challenge PVT methodology early—before trial if possible—using McWhirter and any applicable federal court orders restricting multiple-PVT-based malingering conclusions.
- Document litigation stress impact with a treating psychiatrist who can testify that symptom worsening during litigation is a known neurobiological phenomenon, not evidence of secondary gain.
- Educate the jury panel during voir dire about the difference between functional and fabricated, using the BMJ Neurology 2025 framing that FND is a “very common condition” producing genuine, severe disability—not a synonym for lying.
Frequently Asked Questions
Can a plaintiff have both TBI and FND at the same time?
Yes, and this is one of the most important clinical and litigation realities of 2026. The Life journal scoping review published in June 2026 confirmed that PPCS and FND have “substantial overlap” and that the interface between them “remains poorly synthesised.” A traumatic brain injury can trigger functional neurological symptoms, meaning both diagnoses can coexist in the same patient. Defense teams frequently present FND as a mutually exclusive alternative to organic TBI—the science does not support that framing. A forensic neuropsychiatrist retained by the plaintiff can explain the co-occurrence model and prevent the jury from treating these as an either/or choice.
How does a defense team use FND to reduce a plaintiff’s recovery?
The defense strategy typically follows a predictable three-step pattern. First, a defense neuropsychologist administers performance validity tests and characterizes any failures as evidence of reduced effort. Second, a defense neurologist testifies that negative imaging rules out structural injury. Third, a defense psychiatrist or neurologist labels the symptom complex as “functional” or, in older terminology, “compensation neurosis”—implying the symptoms exist primarily because litigation provides financial incentive. Research tracking settlement outcomes shows this combined argument reduces jury awards by 30 to 50 percent compared to cases where organic TBI is uncontested. The functional neurological disorder post-concussion syndrome TBI misdiagnosis narrative is therefore not a neutral diagnostic observation—it is a damages reduction tool.
What makes performance validity testing unreliable as a malingering indicator?
Performance validity tests are psychometric instruments designed to detect reduced effort during neuropsychological testing. Individually, with appropriate cutoffs, they have documented sensitivity and specificity. The problem documented in McWhirter et al. and cited in a federal court order in 2024 is that administering multiple PVTs in a single battery compounds false-positive failure rates to the point where the scientific validity of a “malingering” conclusion is undermined. A plaintiff who is genuinely cognitively impaired by TBI and is also experiencing testing anxiety, fatigue, or pain may fail one or more PVTs without any intentional effort suppression. Plaintiffs’ counsel should file Daubert motions targeting the specific malingering inference—not the underlying cognitive testing—when multiple PVTs were used.
Why is a forensic neuropsychiatrist more valuable than a neurologist or neuropsychologist in these cases?
A neurologist can document structural findings but has no psychiatric training to address co-occurring depression, PTSD, or somatization. A neuropsychologist can quantify cognitive deficits but is typically restricted by courts from opining on brain-behavior causation—whether the specific injury caused the specific behavioral outcome. A forensic neuropsychiatrist combines neuroimaging interpretation, psychiatric differential diagnosis, and causal chain analysis in a single, integrated expert opinion. This unified structure is far harder to fracture on cross-examination because attacking one component does not collapse the others. With fewer than 20 board-certified forensic neuropsychiatrists in the country as of 2026, identifying and retaining one early is both strategically essential and practically competitive—your opponent is looking for the same expert.
How does the discovery rule protect TBI plaintiffs who were initially misdiagnosed with FND?
The discovery rule tolls the statute of limitations until the plaintiff knew or reasonably should have known that they sustained an injury attributable to another’s conduct. In functional neurological disorder post-concussion syndrome TBI misdiagnosis cases, early-treating physicians sometimes attribute symptoms to stress, adjustment disorder, or functional causes without connecting them to the traumatic event. If a plaintiff was told their symptoms were “functional” or “stress-related” for months or years before a correct TBI diagnosis was made, a strong argument exists that the limitations clock did not begin until the accurate diagnosis was reached. Tennessee 2026 case law confirms courts are receptive to this argument where the diagnostic ambiguity was genuine. Counsel should document every instance of misdiagnosis and every treating note attributing symptoms to non-traumatic causes to build the tolling timeline.
Legal disclaimer: This article is provided for general educational purposes only and does not constitute legal advice; readers should consult a licensed attorney in their jurisdiction regarding the specific facts of their case.
Robert Callahan is a TBI and Catastrophic Injury Researcher with extensive knowledge of personal injury law and settlement values across the United States. With years of experience analyzing brain injury / tbi claims only cases, Robert helps injury victims understand their legal rights and the potential value of their claims. Robert is not an attorney and the information provided is for educational purposes only.